India to Launch First Indigenous H5N1 Bird Flu Vaccine on 20 November
ICAR-NIHSAD develops vaccine targeting H5N1 avian influenza Clade 2.3.2.1a
19 November 2026, New Delhi: India will launch its first indigenous inactivated vaccine against Highly Pathogenic Avian Influenza (HPAI) H5N1, Clade 2.3.2.1a, for chickens on 20 November 2026.
Union Minister for Agriculture and Farmers Welfare and Rural Development Shivraj Singh Chouhan will launch the vaccine for the country at the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal, Madhya Pradesh.
The vaccine has been developed by ICAR-NIHSAD, Bhopal, to provide protection against H5N1 virus strains belonging to Clade 2.3.2.1a circulating in India.
H5N1 Outbreaks in India
Highly Pathogenic Avian Influenza, commonly known as bird flu, affects poultry and can cause mortality of nearly 100% among infected birds. Outbreaks can result in economic losses for poultry farmers due to bird culling and trade restrictions.
Since the first detection of avian influenza in India in 2006, the country has reported more than 500 combined outbreaks involving H5N1 and H5N8 subtypes.
The 2006 outbreak resulted in estimated direct and indirect losses of Rs. 2,200–3,000 crore. An outbreak in Manipur caused losses equivalent to 0.5% of the state’s GDP.
According to the Ministry of Agriculture and Farmers Welfare, a major bird flu outbreak could reduce India’s GDP growth by up to 1.5%, while more than 20% of the country’s poultry population could be at risk if the disease spreads without control.
H5N1 Clade 2.3.2.1a
Studies have identified H5N1 Clade 2.3.2.1a as a strain responsible for a majority of bird flu outbreaks in chickens. Infections involving this strain have also been detected in mammals and other animal species, along with three human cases.
The World Health Organization (WHO) has reported 1,003 human cases of H5N1 avian influenza, including 479 deaths, across 25 countries, including India, since 2003.
According to the Ministry, no specific commercial vaccine is currently available against H5N1 Clade 2.3.2.1a. The vaccine developed by ICAR-NIHSAD is intended to address this gap by targeting the virus strains circulating in Indya.
Also Read: Mahindra Launches 50 HP Compact Harvester Harvest Yuva for Small Farms
Global Agriculture is an independent international media platform covering agri-business, policy, technology, and sustainability. For editorial collaborations, thought leadership, and strategic communications, write to pr@global-agriculture.com







